According to the national “Veterinary Drug Administration Regulations” and “Veterinary Drug Registration Measures”, the swine fever genetically-engineered subunit vaccine (CHO-133D), which Jinyu Baoling Biopharmaceuticals Co., Ltd., a wholly-owned subsidiary of Jinyu Biotechnology Co., Ltd. participated in the development and development of the swine fever genetically-engineered subunit vaccine () was approved as a new veterinary drug, and issued a “New Veterinary Drug Registration Certificate”.
生物股份：子公司取得新兽药注册证书
Biotech Co., Ltd.: The subsidiary obtained a new veterinary drug registration certificate
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.